Topcon Healthcare Signs Acquisition Agreement for Toku, Inc. to Expand Oculomics Reach in Eyecare

▤ Summary

Topcon Healthcare signed a definitive agreement to acquire Toku, an AI health technology company focused on retinal-image-based risk screening. Toku’s platforms analyze standard eye images to assess cardiovascular risk, biological aging, and chronic kidney disease in real time. Topcon plans to integrate Toku’s algorithms into its connected care ecosystem and expand AI-driven screening across primary care, eyecare, and telehealth. The deal also aims to accelerate regulatory clearances, commercialization, and broader adoption of oculomics-based health assessments.

▦ Linked Companies

Topcon Healthcare, Inc.

$10M to $25M